Brief: Chinook Therapeutics Announces Proposed Public Offering
24/05/2022 21:46
May 24 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING
* CHINOOK - INTENDS TO USE NET PROCEEDS FROM OFFERING TO
CONTINUE
PHASE 3 ALIGN, PHASE 2 AFFINITY TRIALS OF ATRASENTAN, FUND PHASE
3 TRIAL OF BION-1301
Source text for Eikon: ID:nGNXc4rvZ4
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc